Vol.
26
No.
13
March 31, 2000Mar 31, 2000
Free

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

Sieber Direct Communications At NCI, Reorganizing Offices.

“5 A Day” Review Underway to Check Program’s Health at NCI.

AACR Honors Nine Cancer Researchers, Clinicians.

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

Bristol-Myers, Karolinska In Collaboration For Studies.

Antigenics Begins Phase II Trial Of Oncophage for NHL.

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

RFP: Intellectual Property.

Login